XTX Topco Ltd - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 57 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
XTX Topco Ltd ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$330,532
-51.9%
151,620
+165.6%
0.07%
-52.7%
Q4 2022$686,708
+727.4%
57,083
+214.1%
0.15%
+329.4%
Q2 2022$83,000
-45.0%
18,174
+72.2%
0.03%
-60.0%
Q4 2021$151,00010,5560.08%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 576,317$1,504,0001.50%
Phoenix Holdings Ltd. 197,763$483,0000.02%
Frontier Wealth Management LLC 71,900$188,0000.02%
GSA CAPITAL PARTNERS LLP 19,659$51,0000.01%
Rossmore Private Capital 15,061$39,0000.01%
ETF MANAGERS GROUP, LLC 98,486$255,0000.01%
Virtu Financial LLC 10,450$27,0000.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$15,0000.01%
Sterling Investment Advisors, Ltd. 3,150$8,0000.00%
Qube Research & Technologies Ltd 75,395$197,0000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders